The study focused on two proteins that appear on the surface of immune cells, B and T lymphocyte attenuator (BTLA) and herpesvirus entry mediator (HVEM). BTLA and HVEM form a protein complex as ...

AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, for treating moderate-to-severe atopic dermatitis (AD), also known as ...

A draft "State Policy and Revenue Management Ordinance, 2025 was approved last month proposing to dissolve the NBR ...